                         SEQUENCE LISTING

<110>  H. Lee Moffitt Cancer Center & Research Institute
 
<120>  Method of Developing a Vaccine Using Peptide-Poly IC Complexes

<130>  1560.158.PRWO

<150>  US 61/602,668
<151>  2012-02-24

<150>  US 61/473,337
<151>  2011-04-08

<160>  15    

<170>  PatentIn version 3.5

<210>  1
<211>  6
<212>  PRT
<213>  artificial sequence

<220>
<223>  hydrophic residue string to add to epitope

<400>  1

Met Phe Val Met Phe Val 
1               5       


<210>  2
<211>  9
<212>  PRT
<213>  artificial sequence

<220>
<223>  peptide epitope Trp 1 455/9m

<400>  2

Thr Ala Pro Asp Asn Leu Gly Tyr Met 
1               5                   


<210>  3
<211>  3
<212>  PRT
<213>  artificial sequence

<220>
<223>  3 amino acid linking sequence

<400>  3

Met Phe Val 
1           


<210>  4
<211>  19
<212>  PRT
<213>  artificial sequence

<220>
<223>  7 arginine tail epitope Trp1 455/9m

<400>  4

Arg Arg Arg Arg Arg Arg Arg Met Phe Val Thr Ala Pro Asp Asn Leu 
1               5                   10                  15      


Gly Tyr Met 
            


<210>  5
<211>  19
<212>  PRT
<213>  artificial sequence

<220>
<223>  7 lysine tail epitope Trp1 455/9m

<400>  5

Lys Lys Lys Lys Lys Lys Lys Met Phe Val Thr Ala Pro Asp Asn Leu 
1               5                   10                  15      


Gly Tyr Met 
            


<210>  6
<211>  19
<212>  PRT
<213>  artificial sequence

<220>
<223>  7 glutamic acid tail epitope Trp1 455/9m

<400>  6

Glu Glu Glu Glu Glu Glu Glu Met Phe Val Thr Ala Pro Asp Asn Leu 
1               5                   10                  15      


Gly Tyr Met 
            


<210>  7
<211>  15
<212>  PRT
<213>  artificial sequence

<220>
<223>  3 arginine tail epitope Trp1 455/9m

<400>  7

Arg Arg Arg Met Phe Val Thr Ala Pro Asp Asn Leu Gly Tyr Met 
1               5                   10                  15  


<210>  8
<211>  9
<212>  PRT
<213>  artificial sequence

<220>
<223>  peptide epitope hpv16-e7 49

<400>  8

Arg Ala His Tyr Asn Ile Val Thr Phe 
1               5                   


<210>  9
<211>  9
<212>  PRT
<213>  artificial sequence

<220>
<223>  peptide epitope hpv16-e7 49/1a

<400>  9

Ala Ala His Tyr Asn Ile Val Thr Phe 
1               5                   


<210>  10
<211>  16
<212>  PRT
<213>  artificial sequence

<220>
<223>  peptide epitope Trp1 455/9m with hydrophobic tail

<400>  10

Leu Met Phe Val Met Phe Val Thr Ala Pro Asp Asn Leu Gly Tyr Met 
1               5                   10                  15      


<210>  11
<211>  13
<212>  PRT
<213>  artificial sequence

<220>
<223>  Trp1 455/9m with hydrophobic tail (Pam)2 KMFV

<400>  11

Lys Met Phe Val Thr Ala Pro Asp Asn Leu Gly Tyr Met 
1               5                   10              


<210>  12
<211>  6
<212>  PRT
<213>  artificial sequence

<220>
<223>  6 hydrophobic amino acid chain LMFMFV

<400>  12

Leu Met Phe Met Phe Val 
1               5       


<210>  13
<211>  8
<212>  PRT
<213>  artificial sequence

<220>
<223>  8 hydrophobic amino acid epitope

<400>  13

Ser Val Asp Phe Phe Val Trp Leu 
1               5               


<210>  14
<211>  2
<212>  PRT
<213>  artificial sequence

<220>
<223>  hydrophilic amino acid linker

<400>  14

Ser Ser 
1       


<210>  15
<211>  12
<212>  PRT
<213>  artificial sequence

<220>
<223>  peptide with hydrophilic linker and minimal T cell epitope

<400>  15

Cys Ser Ser Thr Ala Pro Asp Asn Leu Gly Tyr Met 
1               5                   10          


